Earnings call transcript: MindWalk Inc. reports strong Q1 2025 performance, rebrands from ImmunoPrecise Antibodies
PositiveFinancial Markets

MindWalk Inc. has reported a strong performance for Q1 2025, showcasing significant growth and a successful rebranding from ImmunoPrecise Antibodies.
Editor’s Note: This news is important as it highlights the company's successful transition and growth, which could attract more investors and boost its market presence.
— Curated by the World Pulse Now AI Editorial System